Kevin R. Flaherty, MD, MS Professor of Medicine Director, University of Michigan Interstitial Lung Disease Program Chair, Pulmonary Fibrosis Foundation Clinical Care Network/Registry Steering Committee Ann Arbor, MI
Mary E. Strek, MD Professor of Medicine Director, University of Chicago Interstitial Lung Disease Program Chair, Pulmonary Fibrosis Foundation Clinical Care Network Registry Ancillary Studies Committee Chicago, IL
AMA PRA Category 1 Credit™ Medium
Mobile + Online on Univadis
Treatment of ILD can be a challenge for clinicians; poor outcomes and health-related quality of life attest to the significant care gaps and treatment limitations that remain. Advances in the treatment of ILD, and particularly in idiopathic pulmonary fibrosis (IPF), hold promise for improved care and patient outcomes. This activity will examine management strategies for IPF.
. Target Audience
This educational activity is designed to meet the needs of pulmonologists, radiologists, pathologists, primary care and other health care providers who encounter patients with ILD.
Upon completion of this educational activity, the participant should be able to:
Recognize risk factors for IPF.
Use current evidence-based guidelines for the treatment of IPF to create individualized management strategies for patients with IPF.
Describe conditions commonly found comorbidly with IPF and recognize the role of treating these conditions in a comprehensive IPF management plan.
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine, asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME defines "relevant financial relationships" as financial relationships in any amount occurring within the past 12 months including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Dr. Flaherty discloses that he has consulted for Boehringer Ingelheim, Inc., Celgene, Genentech/Roche, Sanofi-Genzyme, and Veracyte, and received grant support from Boehringer Ingelheim, Inc. and Genentech/Roche.
Dr. Strek discloses that she has received grant support from Boehringer Ingelheim, Inc. and Genentech/Roche, and served on an advisory board and speakers bureau for Boehringer Ingelheim, Inc.
Mahira Zec Bonomo, University of Chicago, Director for CME, has nothing to disclose.
Kathleen Hines, MCM Education VP, Editorial Services, has nothing to disclose.
Terry Ann Glauser, MD, MPH, MCM Education VP, Medical Affairs, has nothing to disclose.
Faculty members are required to inform the audience when they are discussing off-label or unapproved uses of devices or drugs. Devices or drugs that are still undergoing clinical trials are identified as such and should not be portrayed as standard, accepted therapy. Please consult full prescribing information before using any product mentioned in this activity. If using products in an investigational, off-label manner, it is the responsibility of the prescribing physician to monitor the medical literature to determine recommended dosages and uses of the drugs. Neither the publisher nor the providers promote the use of any agent outside of approved labeling. Credit Statements
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago Pritzker School of Medicine and MCM Education. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses and other health care professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credits™. from organizations accredited by the ACCME, please consult your professional licensing board. Commercial Support Statements
This activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
* Click "Start Program" and log into program on QuantiaMD.com
* Take the pre-test
* Review the activity
* Take the post-test and score 80%
* You are allowed a total of 3 attempts
* Complete the evaluation
* View, print, or save a CME certificate verifying your
credit/participation in this activity
Computer Requirements: Minimum System Requirements: • Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7 • Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers
There is no charge for CME credit.
©2018 MCM Education. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, The University of Chicago Pritzker School of Medicine, or Boehringer Ingelheim Pharmaceuticals, Inc. Any medications, diagnostic procedures, or treatments discussed by the program presenters should not be used by clinicians or other health care professionals without first evaluating their patients' conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.